Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00617)

• Formulation Name: Alendronic acid 35 mg tablet
• Company: Ascend Laboratories; Blu Pharmaceuticals; Bryant Ranch Prepack; Hangzhou Minsheng Binjiang Pharm; NuCare Pharmaceuticals; RemedyRepack; Virtus Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Alendronate	(DMY2KX9)	Bone Paget disease		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant